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Abstract 
Perforin (pfp)-mediated cytotoxicity is one of the principal immunosurveillance mechanisms 
involved in the fight against cancer. However, its importance in spontaneous epithelial cancer is 
still poorly defined. Here, we use a realistic mouse model which displays many features that are 
equivalent to human pathology, to evaluated the role of pfp-dependent immunosurveillance by 
comparing tumor progression in rat ErbB-2 (neu) transgenic, pfp-proficient (neu+/pfp+) or pfp-
deficient (neu+/pfp-) BALB/c male mice. Adult neu+/pfp+ males developed poorly differentiated 
salivary carcinomas, whereas neu+/pfp- males displayed their salivary carcinomas noticeably earlier 
and showed zones of more highly differentiated tumor, indicating that pfp-mediated 
immunosurveillance is able not only to delay the growth kinetic of an aggressive epithelial tumor, 
but also to shape its histology. The role of pfp-mediated immunosurveillance appeared to be of even 
more dramatic importance against the less aggressive male mammary carcinomas. In neu+/pfp+ 
males, the incidence of mammary carcinomas was a sporadic and late event. By contrast in 
neu+/pfp- males their incidence was four-times higher. This higher cancer incidence was associated 
with a two-fold higher occurrence of persisting mammary remnants, a major risk factor for 
mammary cancer in male mice, and one which would appear to be due to pfp’s previously 
unidentified involvement in male mammary gland rejection during embryogenesis. 
This work thus provides further proof of the complex role that the immune system plays in 
the body and gives new insight into the pathogenesis of epithelial tumors, demonstrating that the 
penetrance and malignancy of a tumor may be dramatically affected by pfp-dependent mechanisms. 
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Introduction 
Observational studies linked to clinical-outcome analysis in cancer patients that have been 
carried out in recent years have displayed the prognostic and predictive value of the tumor 
microenvironment inflammatory state. This has generated a new wave of interest in the 
immunosurveillance phenomenon (1). Natural immune surveillance against the onset of cancer is 
one of the most important tenets in experimental tumor immunology (2, 3). Extensive evidence 
have shown that immunodeficient mice develop more carcinogen-induced and spontaneous cancers 
than wild-type mice, and that tumor cells from immunodeficient mice are more immunogenic than 
those from immunocompetent mice (4). Numerous studies have elucidated several molecular (5) 
and cellular (6, 7) immune surveillance mechanisms that hamper tumor onset and shape its growth. 
However, as their role in spontaneous epithelial cancer is poorly defined, the importance of 
immunosurveillance in the control of most common human cancers is still difficult to grasp. 
Alterations inthe ERBB-2 oncogene and its signal transduction pathways are amongst the 
causes of epithelial cell neoplastic transformation, carcinoma progression, metastatic spreading and 
resistance to therapy (8). In human pathology, ERBB-2 (Her-2) overexpression and mutations are 
evident in 30-40% of epithelial tumors and are associated with the early onset of precancerous 
lesions, increased metastasis and severe prognoses (9). In human breast cancer, gene amplification 
and protein overexpression of ErbB-2 are associated with poor prognosis (10). Similarly, high-
grade human salivary gland carcinomas harbor increased ErbB-2 protein expression and gene copy 
number (11). 
In rats, a single point mutation in the transmembrane domain favors ERBB-2 homo- and 
hetero-dimerization and transforms the rat proto-oncogene into a dominant oncogene (neu) (12). In 
a neu transgenic BALB/c (BALB-neuT) mouse strain, females develop fast-growing mammary 
carcinomas in all their mammary glands (13). However, mammary neu+ carcinomas in BALB-neuT 
males are late sporadic events and the prominent cause of death is multifocal poorly differentiated 
acinic adenocarcinoma that initially involves the parotid and then the submandibular glands (14).At 
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4 weeks of age, males display multiple foci of atypical salivary gland hyperplasia, at the duct and 
acinic level, that progress to become poorly differentiated carcinomas that are clinically evident at 
the 26th week of age (14). 
Their consistent genetic predisposition to developing lethal carcinoma, their progression 
through well defined stages and thelong-lasting interaction with the host microenvironment make 
BALB-neuT mice an appealing model for the evolution of the role that immunosurveillance plays 
in inhibiting neu+ epithelial tumors. The consistent genetic predisposition to developing lethal 
carcinomas, their progression through well-defined stages and the long-lasting interaction with the 
host microenvironment make BALB-neuT mice an appealing model for the evaluation of the role 
that immunosurveillance plays in inhibiting neu+ epithelial tumors. Previous studies on female 
BALB-neuT mice have shown that despite the absolute penetrance and aggressive tumorigenesis 
caused by neu transgene expression in the mammary glands and the existence of CD8 T cell central 
immune tolerance to the rat neu protein product (15, 16), pfp- and complement-mediated 
immunosurveillance mechanisms significantly impair the onset of mammary carcinomas (17, 18). 
We herein compare the ability of pfp-mediated immunosurveillance to inhibit neu+ salivary 
carcinomas, with high penetrance, and mammary carcinomas with a slower progression and lower 
penetrance in BALB-neuT male mice. 
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Materials and Methods 
 
Mice.BALB-neuTmale mice (13)from Biogem, Ariano Irpino, Italywere crossed with pfp-/- 
BALB/c females (17). Heterozygous pfp+/- and neu+/- F1 male mice were then backcrossed with pfp-
/-or pfp+/+ BALB/c females. The progeny was genotyped to discriminate between normal (neu-
/pfp+), pfp-/-(neu-/pfp-), those heterozygous for the neu transgene (neu+/pfp+), and those 
heterozygous for the neu transgene and pfp -/-(neu+/pfp-).A first line was generated from a BALB/c 
pfp-/- female received from the Peter MacCallum Cancer Centre, East Melbourne, Australia that was 
crossed with a BALB-neuT male re-derived in SPF conditions by Charles River, Calco, Italy, and 
maintained at the Dept. Clin. Biol. Sci., Orbassano, Italy (DCBS Selection). A second line was 
generated later at the Mol. Biotechnol. Ctr. (MBC Selection) from a BALB/c pfp-/- female 
originally from the Peter MacCallum Cancer Centre but received from NIAID/NIH, Bethesda, MD 
where a colony of these mice is maintained, by courtesy of Dr. Robert Wiltrout, that was crossed 
with a BALB-neuT male re-derived by Biogem, Ariano Irpino, Italy. Tumor onset was evaluated as 
previously described (13).BALB/c mice knockout for the interleukin (IL)-15 gene (neu-/IL15-) were 
a gift from Dr. Silvia Bulfone-Paus (Research Center Borstel, Germany) to Dr. Pier-Luigi Lollini. 
All mice were maintained in specific pathogen free conditions (Allentown Caging Equipment, 
Allentown Inc., Allentown, NJ)and treated in conformity with current European guidelines and 
policies. The Bioethical Committee of the University of Torino approved the experimental plan. 
 
Morphologic analysis.Salivary glands were frozen in a cryo-embedding medium or fixed in 
formalin and embedded in paraffinfor histological and immunohistochemical analyses. Sections 
were incubated with the following primary antibodies:rabbit polyclonal anti-human Her-2 (A0485; 
Dako Corporation, Carpentaria, CA), mouse mAb to Proliferating Cell Nuclear Antigen (PCNA) 
(M0879;Dako Corporation), anti-CD3 (Ab828, Abcam, Cambridge, UK); anti TCR γδ (553175, BD 
Pharmingen, San Diego, CA).Immunocomplexes were detected using Streptavidin Peroxidase 
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(Thermo Scientific-Lab Vision Corporation, Freemont, CA) and either the DAB Chromogen 
System (Dako Corporation) or the Bajoran Purple Chromogen System (Biocare Medical, Concord, 
CA). The whole mount and immunohistochemical preparations of mammary glands were carried 
out as previously described (17). For mammary gland reabsorption studies, embryos were removed 
from the uterus at E14.5 and E16.5, fixed for 1 h in PFA1% and embedded in OCT and cut in serial 
sections. Male and female embryos were distinguished by PCR as described (19). 
 
Cytometry of tumor infiltrating leukocytes. Freshly isolated tumor specimens of 7-8 mm 
mean diameter were dissociated as previously described (18) to obtain cellular suspensions that 
were treated with anti CD16/CD32 (01245B, BD Bioscences, San José), and stained with: anti-
CD49b PE (130-091-816), anti-CD45 VioGreen (130-097-294), anti-CD8a VioBlue (130-094-360), 
anti-CD3e FITC (130-092-962), all from Miltenyi Biotech (Calderara di Reno, Italy), and anti-γδ 
TCR PE/Cy7 (118124, Biolegend, San Diego, CA). Samples were acquired and analyzed on the 
CyAn ADP using Summit 4.3 software (DakoCytomation, Heverlee, Belgium). 
Bone marrow transplantation and NK cell depletion. Eight-week-old neu+/pfp+ male mice 
were exposed to a total dose of 7.8 Gywhole-body irradiation using a Gilardoni RADGIL X-ray 
generator (GilardoniS.p.A, Lecco, Italy).Twenty-four hours after irradiation, mice intravenously 
received 15 x 106 bone marrow cells (BMC) isolated from the femur and tibia of neu-/pfp-or neu-
/pfp+ males and were then monitored for the appearance of salivary carcinoma. Non transplanted, 
irradiated control mice died within 2 weeks. To verify bone marrow engraftment, mice were bled 
and peripheral blood cells were stained withmAbanti-CD45 (130-091-811,MiltenyiBiotech), anti-
B220/CD45R (558108), anti-CD90.1/Thy1.2 (553003), anti CD8a (553033), anti-CD49b (553858) 
(all from BD Pharmingen), anti-CD11b (101206), anti-CD4 (100528) (all from Biolegend) and 
analyzed by flow cytometry one month after the injection of BMC.Only transplanted mice 
displayinglymphoid and myeloid cell levels comparable to neu-/pfp+ micewere evaluated. NK cell 
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depletion was performed on neu+/pfp+ males irradiated and reconstituted with BMC from neu-/pfp+ 
mice, starting from 30 days after BMC transplantation, and on untreated 6-week old neu+/pfp+ 
males.Mice received intraperitoneal injections of 0.2 ml of phosphate-buffered saline containing a 
1:20 dilution of anti-asialo GM1 rabbit anti-serum (Wako Pure Chemicals Industries, Osaka, Japan) 
on days 0, 1 and 2 and then once a week until the salivary carcinoma became palpable. Controls 
were injected with normal rabbit serum (NRbS) (GIBCO, Grand Island, NY). 
 
 Statistical analysis.Statistical differences were evaluated using GraphPad software 5.0 
(GraphPad Inc. San Diego, CA). The Mantel-Cox log-rank testwas used to assess the differences in 
tumor incidence and overall survival. Differences in the frequency of tumors and mammary gland 
remnants were evaluated using the chi-square test with Yates’ correction. All the other statistical 
differences were assessed using the two-tailed unpaired Student’s t test. 
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Results 
 
Pfp hampers the onset and shape the histologyof neu+ salivary carcinomas in male mice. 
Salivary carcinomasare the prominent cause of death in neu+males. The faster progression of 
these tumors in neu+/pfp- as compared to neu+/pfp+ males that was initially observed in a small 
number of males from the DCBS Selection (SupplementalFig. 1) spurred us to study the kinetics of 
these carcinomas in a larger number of males fromthe MBC Selection.Salivary carcinomas became 
palpable significantly earlier in neu+/pfp- as compared to neu+/pfp+ mice (Fig. 1A; p< 0.0001). 
While salivary carcinomas appeared from the 26th week of age in neu+/pfp+ males, neu+/pfp- males 
had already started to develop salivary tumors at the 18th week. Similarly, overall survival was 
significantly shorter in neu+/pfp- than in neu+/pfp+ male mice (Fig. 1B; p< 0.0001). 
At 8 weeks of age, both neu+/pfp+ and neu+/pfp- males displayed small foci of atypical 
hyperplasia surrounded by numerous reactive cells in the salivary intercalated ducts and the serous 
acini (Fig. 2A and Fig. 2B, respectively). In neu+/pfp+ males the carcinomas that became palpable 
from the 26th week of age appeared to have been uniformly generated by the confluence and 
evolution of multiple foci of ductal hyperplasia, and were finally composed of solid lobules of 
uniform cells with no glandular differentiation (Fig. 2C), high mitotic activity (Fig. 2D), and high 
neu expression (Fig. 2E). By contrast, the quick outgrowth of poorly differentiated (Fig. 2F), highly 
proliferative (Fig. 2G), and highly neu+ (Fig. 2H) carcinomas in neu+/pfp- males was accompanied 
by the expansion of several areas of variously differentiated acinic carcinomas characterized by 
zones with clear cells (Fig. 2I) and others with large cells, resembling normal serous cells, 
organized in small nodules (Fig. 2L). Both areas were characterized by low proliferative activity 
(Fig. 2J and Fig. 2M) and high neu expression (Figure 2K and Fig. 2N). 
 
Salivary carcinomas are infiltrated by pfp-dependent effector immune cells. 
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Various effectors immune cells are pfp-dependent (CD8+αβ T, NK, NKT, and γδ T cells), 
most of which are CD3+. In fact, infiltrating cells in salivary carcinomas from both neu+/pfp+ and 
neu+/pfp- mice were prominently CD3+, as shown by immunohistochemistry (Fig. 3A and Fig. 3B). 
A cytofluorimetric analysis was also performed to evaluate the relative amount of pfp-dependent 
effector immune cells in salivary tumors. As shown in Figure 3C, CD8+αβ T, γδ T, and NK cells 
(identified as CD3- CD49b+) were detected in the salivary tumors of both neu+/pfp- and neu+/pfp+ 
mice, whereas NKT cells (identified as CD3+ CD49b+) were present at very low percentages. The 
negligible presence of NKT cells suggests that these cells cannot be the major effectors that hamper 
neu+ salivary carcinogenesis, while CD8+αβT, γδ T, and NK cells might all contribute to this 
immunosurveillance phenomenon. 
 
T cells are not the principal players in immunosurveillance fight against neu+ salivary 
carcinomas. 
To assess which pfp-dependent effector cell population was principally involved in 
hampering neu+ salivary carcinogenesis, we decided to perform bone marrow chimeras by 
reconstituting lethally irradiated 8-week old neu+/pfp+ male mice with BMC from either neu-/pfp- or 
neu-/pfp+ male donors; some of the neu-/pfp+ reconstituted mice were also depleted of NK cells. 
Since the generation of γδ T cells mainly occurs during the fetal life, BMC reconstituted mice have 
CD8+ αβ T and NK cells, but are virtually devoid of γδ T cells (Supplemental Fig. 2). Salivary 
carcinoma onset occurred significantly earlier (p < 0.0001) in mice reconstituted with neu-/pfp+ 
BMC (Fig. 4A) as compared to untreated neu+/pfp+ mice (Supplemental Fig. 3). These accelerated 
kinetic is due to the lethal irradiation and the time required by transplanted BMC to reconstitute the 
mouse, but a possible contribution from the lack of γδ T cells cannot be ruled out. Nevertheless, 
salivary carcinomas arising in males reconstituted with neu-/pfp+ BMC were uniformly poorly 
differentiated carcinomas with severe atypical features and a high proliferative rate (Fig. 4B and 
Fig. 4C), thus very similar to those that arise in untreated neu+/pfp+ males (Fig. 2C-E). Moreover, 
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when mice reconstituted with neu-/pfp+ BMC where depleted of NK cells, they displayed 
significantly anticipated salivary carcinoma onset (p = 0.02) as compared to not-depleted ones. 
Here, the kinetics was very similar to what found in mice reconstituted with neu-/pfp- BMC (Fig. 
4A). The histological features of the salivary carcinomas that arose in mice reconstituted with neu-
/pfp+ BMC and depleted of NK cells (Fig. 4D-G) and those that arose in mice reconstituted with 
neu-/pfp- BMC (not shown) were also very similar. Besides poorly differentiated (Fig. 4D) and 
highly proliferative areas (Fig. 4E), they also displayed several areas of differentiated acinic 
carcinomas with clear cell features, pronounced glandular differentiation (Fig. 4F), and lower 
proliferative rate (Fig. 4G), as found in untreated neu+/pfp- mice (Fig. 2F-N). Taken together, these 
data suggest that the main players in the immunosurveillance against neu+ salivary carcinomas may 
be NK cells, but certainly not CD8+αβ T cells, and probably not γδ T cells either. 
 
Salivary carcinogenesis is delayed by NK cells. 
To better evaluate the role of NK cells, neu+/pfp+ males were depleted of NK cells via the 
chronic administration of anti-asialo GM1 antibodies. Salivary carcinoma onset was significantly 
faster in these mice than in neu+/pfp+ males treated with the control isotype and similar to that of 
neu+/pfp- mice (Fig. 5A, p = 0.003 and p = 0.4, respectively). Moreover, salivary carcinomas that 
arose in NK cell-depleted neu+/pfp+ males display areas with poor differentiation, high proliferation 
and neu expression (Fig. 5B-D) together with others with various degree of differentiation, lower 
proliferative rate and high neu expression (Fig. 5E-J). These results confirm the key role of NK 
cells not only in making the kinetic of salivary carcinogenesis slower but also in doingthe immune 
selection of premalignant cells that will become true cancer in salivary glands. 
 
Pfp blocks neu+ mammary carcinomas in male mice. 
The onset of neu+ mammary carcinomas is a late event displayed by less than 20% of one-
year-old neu+/pfp+ males that survive salivary carcinomas. Asurprisinglyhigher incidence of 
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mammary cancer was first seen in a small number of neu+/pfp- males from the DCBS selection 
(data not shown). When this observation was reexamined on a large number of males from the 
MBC selection it was evident that more than 70% of neu+/pfp-males display a mammary carcinoma 
within one year of age (Fig.6A). Whole mountanalysis of the most technically accessible 2nd, 3rd 
and 4th mammary glands,showed that microscopic mammary carcinomas were evident in 8%of25-
30 week-old neu+/pfp+ males, but in over 36% of age-matched neu+/pfp- males. This reveals 
that,even at this earlier time, a fourfold higher carcinoma incidence is microscopically evident in 
neu+/pfp-than in neu+/pfp+ males (Fig.6B, p = 0.003). These carcinomas homogeneously consist in 
solid nodular aggregates that arise from ducts of persisting mammary remnants (Fig.6C and Fig.6D) 
composed of moderately differentiated atypical ductal neu+ cells surrounded by delicate 
vascularized stromal bundles and a moderate inflammatory infiltrate (Fig.6E-H). 
 
Impaired mammary gland reabsorption in pfp deficient male embryos. 
The triggering of androgen receptors causes the regression of mammary sprouts that 
disappear during late embryogenesis (E15.5) in most male mice glands (20). An evaluation of the 
frequency of the persistence of glandular sprouts in the mammary areas from 20-30-week-old males 
showed that these were evident in only 6.5% of mammary areas in neu+/pfp+ mice, but in about 
14.3% neu+/pfp- micemammary areas (Fig.7A).Persistent mammary sprouts were also evident in 
3.3% of the mammary areas of neu-/pfp+ malesand in 9% ofneu-/pfp- mice.A similar increase in the 
persistenceof mammary remnants was also found in neu-/IL15- males (Fig.7A) that are typically 
devoid of skin intraepithelial γδ T cells(21, 22).These data show that an impaired regression of 
rudimentary mammary tissue is connected with both the deprivation of pfp and intraepithelial γδ T 
cells. Immunohistochemical analysis of mammary buds in male and female embryos of 14.5 and 
16.5 days, showed the presence of γδ T cells only around male mammary buds, confirming the 
possible role of these cells in male mammary gland reabsorption (Fig. 7B and Fig. 7C).The 
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impaired reabsorptionof mammary remnants observed in pfp- males fits in well with the reduced 
involution of mammary glands after lactation in pfp- females (Supplemental Fig. 4). 
The defective regression of mammary sprouts appears to be a major risk factor for 
mammary cancer in adult males. However in neu+/pfp+ males, only 30% of mammary remnants 
were associated with microscopic carcinomas,which instead were present in 75% of mammary 
sprouts persisting in neu+/pfp- males (Fig. 7D). These data show that the protection associated with 
the expression of the pfp gene derives from two distinct effects; a reduction in the number of males 
at risk due to the persistence of mammary remnants, and an efficient block of carcinogenesis in 
those adult neu+ males that have mammary remnants. 
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Discussion 
We have recently exploited the genetic predestination of female BALB-neuT mice to 
mammary carcinogenesis (23) to assess the weight of pfp-mediated (17) and complement-mediated 
(18) natural immunosurveillance towards neu+ mammary carcinomas. We have now extended our 
observation to the role of pfp-mediated mechanism in the surveillance of salivary and mammary 
carcinomas that arise in BALB-neuT males (14).The data obtained show that the pfp deficiency: i) 
reduces the tumor-free survival of these mice; ii) allows for the growth of more differentiated 
salivary tumor histotypes and iii) impairs male mammary sprout reabsorption during 
embryogenesis. 
The slow growing salivary carcinomas are a common cause of death in adult neu+/pfp+ 
males. About 70% of them die before reaching one year of age because of salivary tumor 
outgrowth. Salivary carcinogenesis is more aggressive in neu+/pfp-males. These pfp-deficient mice 
display shorter disease free times and overall survival, with about 95% of them dying by one year 
of age. BMC reconstitution of lethally irradiated neu+/pfp+ males excluded T cells performing a 
prominent role in this pfp-mediated phenomenon, while NK depletion experiments pointed to the 
central role of NK cell-expressed pfp in the inhibition of salivary carcinomas. These findings fit in 
well with our previous observation on the similar key role NK cells play in the control of mammary 
carcinogenesis in neu+/pfp+females (17) and with emerging data from epithelial human tumors that 
demonstrate a significant correlation between the reduced expression of pfp by NK cells and cancer 
progression in patients with pancreatic, gastric and colorectal cancers (24).  
The role of NK cells was not limited to affecting the pace of cancer progression, but also 
sculpted the histotype of salivary carcinomas that become clinically evident. The transforming neu 
transgene is expressed not only by several ductal cells but also by some cells of serous acini in the 
salivary glands of male mice during puberty. Areas of atypical hyperplasia of ductal and acinar 
structures are microscopically evident in the earlier stages of carcinogenesis. However, only poorly 
differentiated monomorphic neu+ carcinomas of ductal origin sneak through the pfp-dependent 
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mechanisms. By contrast, salivary carcinomas that become clinically evident in neu+/pfp-males 
display multiple minor areas of acinic neoplasia with a higher degree of differentiation and lower 
proliferative rate among the large areas of poorly differentiated carcinomas. Similarly, when 
lethally irradiated neu+/pfp+ males were reconstituted with neu-/pfp+ BMC, only poorly 
differentiated carcinomas were able to expand. By contrast, when lethally irradiated neu+/pfp+ 
males were reconstituted with neu-/pfp- BMC, or with neu-/pfp+ BMC but were depleted of NK 
cells, areas of neoplasia with a higher degree of differentiation and lower proliferative rate were 
again found to be components of the outgrowing tumors. Finally, areas of more highly 
differentiated neoplasia were also able to expand when otherwise untreated neu+/pfp+ males were 
depleted of NK cells. These data further support the importance of NK cells not only in 
immunosurveillance, but also in the immunoediting of epithelial cancer (25). 
This pfp-dependent selection of tumor histotype also corroborates data on neoplastic stem 
cells’ increased ability to give rise to tumors when injected into immunocompromised, as compared 
to normal, mice (26, 27). While a few neoplastic stem cells are able to give rise to a tumor in mice 
with an efficient immune system, many others are able to outgrow in those that are 
immunocompromised. This implies that malignant cells with stem cell properties are endowed with 
a different degree of penetrance, suggesting that the cell differentiation expressed by tumors may 
not only be the result of the transformation of cells with distinctive stem cell features, but also of 
the action of transforming stimuli on differentiated cells that are able to regain stem cell functions. 
Those with a higher degree of differentiation, which are therefore less aggressive, such as 
transformed salivary acinar cells, may be blocked by immune surveillance mechanisms, while those 
that are less differentiated, such as mammary and salivary transformed ductal cells, are only 
delayed in their progression.  
Lastly, pfp-deficient BALB-neuT males also display a four times higher incidence of 
mammary carcinomas, showing the importance of pfp-dependent immunosurveillance against 
aggressive tumors with low penetrance.  This surprising finding may result from both immune 
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mechanisms and altered pfp-dependent mammary morphogenesis. In both neu+/pfp+ and neu+/pfp- 
males, moderately differentiated neu+ cells that originate from the ducts of the rudimental 
mammary gland sprouts make mammary carcinomas. Consequently, the persistence of these 
rudiments in a few areas in male mammary pads is a major risk factor. Microscopic examination of 
a large number of mammary areas showed that the frequency of persisting mammary remnants was 
almost twice as high in neu+/pfp-than in neu+/pfp+ males. A higher frequency of persisting 
mammary remnants was also evident in neu-/pfp- males as compared to neu-/pfp+ males. The 
physiological regression of rudimental male mammary gland sprouts takes place during late 
embryogenesis (E15.5) (20). Present data indicate that this regression is impaired in the absence of 
pfp, independently of the expression of the neu transgene. 
γδT cells appear to be the main pfp+ cell population responsible for the reabsorption of 
mammary gland rudiments in male embryos. These cells appear from E14 (28), being the 
predominating pfp+ cell population in these stages of fetal development. Functionally competent 
pfp+ NK cells only appear from E16.5 (29), when the reabsorption of male mammary gland 
rudiments is complete. The observation of similar persisting mammary gland remnant frequency in 
neu-/IL15- and neu-/pfp- male mice corroborates the central role γδ T cells play in the reabsorption 
of the male mammary gland. In effect, IL-15 KO mice are devoid of skin intraepithelial γδ T cells 
since IL15-mediated signals are required for their development (21, 22).  
While the fact that pfp may play a role in placental morphogenesis and in the maintenance 
of a microenvironment that is biased towards Th2 cytokine production (30, 31) has previously been 
recognized, its role in mammary regression during male embryogenesis has not yet been 
established. Moreover, the impairment in the regression of mammary rudiments in pfp- males and 
the defective involution of mammary glands after milking observed in pfp- females, suggest that pfp 
mediated mechanisms play a more diffuse role in mammary gland remodeling.  The presence of 
numerous γδ T cells in lactating mammary glands (32), once again points to the possible 
involvement of these lymphocytes in mammary tissue remodeling. 
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Since the frequency of male mice with at least one mammary area containing mammary 
remnants is almost twice as high among neu+/pfp-than in neu+/pfp+ males, the lack of pfp appears to 
play a marked role in increasing the probability of developing mammary cancer. The fact that the 
incidence of mammary cancer is four times higher in neu+/pfp- males than in neu+/pfp+ males 
suggests that the higher risk of mammary cancer, caused by defective mammary rudiment 
regression, is further enhanced by the lack of pfp-dependent immunosurveillance. In effect, the 
number of mammary remnants associated with a microscopic tumor is about 2.5 times higher at 
weeks 20-30 of age in neu+/pfp- as compared to neu+/pfp+ males. 
In conclusion, our data support the existence of a critical role played by pfp-expressing NK 
cells in both immunosurveillance and immunoediting of neu+ epithelial cancers. They markedly 
delay the onset of mammary and salivary carcinomas and their growth rate, but also sculpt the 
differentiation stage of salivary carcinomas. In addition, our findings have unveiled the previously 
unsuspected involvement of pfp in male mammary gland reabsorption during embryogenesis, 
suggesting the existence of a possible role for γδ T cells in this phenomenon. All together these 
findings provide further proof of the multiple roles that pfp-mediated mechanisms fulfill in cancer 
control and may be important for the development of NK cell-based therapeutic strategies. 
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Captions to figures 
 
 
 
 
 
 
 
 
Figure 1. Salivary carcinogenesis in neu+/pfp- males mice is more aggressive as compared to that 
of neu+/pfp+male mice. (A) Early onset and higher incidence of salivary tumors in neu+/pfp-males 
(n = 38; black solid line) as compared to neu+/pfp+ males (n = 68; black dotted line). (B) Survival 
time of neu+/pfp- (n = 27; black solid line) and neu+/pfp+(n = 50; black dotted line) males. ***, p< 
0.0001, Mantel-Cox log-rank test. 
 
 
 
 
 
 
 
 
Figure 2. Pfp deficiency permits the growth of less aggressive, more differentiated tumor 
histotypes. (A and B) Hematoxylin and eosin staining of salivary glands from 8 weeks old 
neu+/pfp+ (A) and neu+/pfp- (B) male mice. Very similar areas of tubular (ductal) (green contour) 
and acinar (white contour) atypical hyperplasia are evident in both neu+/pfp+ and neu+/pfp- male 
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mice. Nodular aggregates of cells resembling cells of intercalated ducts and pseudo-acinar 
structures composed of enlarged and atypical cells with acinar features are evident. Numerous 
infiltrating inflammatory cells are in close contact with the hyperplastic lesions (black arrows). (C-
N) Distinctive features of salivary carcinomas in 26 to 34-week-old neu+/pfp+ (C-E) and neu+/pfp- 
(F-N) male mice. In neu+/pfp+ male mice sheets of poorly differentiated duct cells with severe 
atypical features homogeneously form clinically evident salivary carcinomas (C) with high 
proliferative activity (D). Clinically evident carcinomas in neu+/pfp- mice display a similarly, 
predominant poorly differentiated histotype (F) associated with large areas of clear cell (I) and well-
differentiated (L) acinic carcinomas whose proliferative activity (J, M) is lower of that of poorly 
differentiated tumors (G). All the carcinoma histotypes are formed of highly neu+ cells (E, H, K, N). 
Results are representative of 9 neu+/pfp+ and 3 neu+/pfp- salivary glands analyzed. Magnification 
x400; insets x1000. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Pfp-dependent effector immune cells equally infiltrate salivary tumors of both neu+/pfp- 
and neu+/pfp+ male mice. (A and B) Immunohistochemical staining of 16 week old neu+/pfp+ (A) 
and neu+/pfp- (B) salivary tumors for CD3 showing a significant amount of infiltrating CD3 
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reactive cells surrounding the hyperplastic lesions. Results are representative of 9 neu+/pfp+ and 3 
neu+/pfp- salivary glands analyzed. Magnification x400. (C) Cytofluorimetric analysis of T (CD3+ 
CD8+), NK (CD3- CD49b+), NKT (CD3+ CD49b+) and γδ T (CD3+γδ+) cells in the salivary tumors 
of neu+/pfp- or neu+/pfp+ demonstrated that these cells infiltrate both tumors. Graph shows the 
percentage ± SEM of CD45+ cells expressing the different markers in neu+/pfp-(n = 3; black bars) or 
neu+/pfp+  (n = 3; white bars) salivary tumors. Three independent experiments were performed and 
a representative one is shown. 
 
 
 
 
 
 
 
 
Figure 4. Salivary carcinogenesis onset is affected by NK cells.(A) A Kaplan-Meier curve 
showing the incidence of salivary tumors in neu+/pfp+ male mice reconstituted with neu-/pfp+ BMC 
(n = 26; black dotted line) or with neu-/pfp- BMC (n = 29; black solid line) or with neu-/pfp+ BMC 
and treated with anti asialo GM1 antibodies (n = 7; grey solid line). *, p = 0.02;Mantel-Cox log-
rank test. (B-G) Histology and immunohistochemistry showed that salivary carcinomas in neu+/pfp+ 
males reconstituted with neu-/pfp+ BMC are poorly differentiated with severe atypical features (B) 
and a high proliferative rate (C) whereas those in males reconstituted with neu-/pfp+ BMC and 
treated with anti-asialo GM1 antibodies display a predominant poorly differentiated histotype (D) 
and a high proliferative rate (E) associated with areas of more differentiated acinic carcinoma with 
clear cell features (F) and lower proliferative activity (G). Results are representative of 4 salivary 
tumors analyzed for each experimental group. Magnification x400. 
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Figure 5. Pfp-mediated NK cell activity delays the onset and changes the differentiation of neu+ 
salivary carcinomas. (A) Kaplan-Meier curve comparing the incidence of salivary carcinomas in 
neu+/pfp+ male mice treated with anti-asialo GM1 (n = 6; grey solid line) and untreated neu+/pfp- 
male mice (n = 5; black solid line) with that of neu+/pfp+ males treated with the control isotype (n = 
9; black dotted line). **, p =0.003, *, p = 0.01, Mantel-Cox log-rank test. (B-J) Histological and 
immunohistochemical analysis shows that salivary carcinomas arising in neu+/pfp+ males treated 
with anti-asialo GM1 display poorly differentiated areas (B) with a high proliferative activity (C) 
and high neu expression (D) coexisting with moderately (E) and well differentiated areas with 
tubular aspects (H) with lower proliferative activity (F, I) and high neu expression (G, J). 
Magnification x400. 
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Figure 6. Pfp deficiency enhances the frequency of mammary tumors in neu+ males. (A) A 
Kaplan-Meier curve showing male mammary tumor incidence in neu+/pfp+ (n = 68; black dotted 
line) and neu+/pfp- (n = 37; black solid line) mice. ***, p<0.0001, Mantel-Cox log-rank test. (B) 
Tumor frequency in neu+/pfp+(n = 50; white bar) and neu+/pfp- (n = 36; black bar) males measured 
by whole mount analysis of the 2nd, 3rd and 4th mammary glands. **, p = 0.003, two-tailed unpaired 
Student’s t test. (C-H) Morphological features of representative mammary tumors in neu+/pfp+ and 
neu+/pfp- male mice. (C and D) Whole mount images of tumor masses (white asterisks) developed 
in mammary gland remnants of neu+/pfp+ (C) and neu+/pfp- (D) males consisting of a few, poorly 
arborized, ducts (arrows). In both groups of mice, neoplastic epithelial cells give rise to aggregates 
of monomorphic moderately differentiated duct atypical cells surrounded by delicate vascularized 
stromal bundles (E and F). Immunohistochemistry reveals homogeneous neu positivity (G and H). 
Whole mount magnification x40; histology and immunohistochemistry magnification x400, insets 
x1000. 
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Figure 7. Defective regression of mammary 
sprouts and potential role of γδ T cells in the 
involution of mammary glands in male mice. (A) 
Frequency of mammary remnants found in the 
areas of 2nd, 3rd, and 4th mammary glands in 20-30 
week-old male mice, as assessed by whole mount 
(neu+/pfp+ n = 292; neu+/pfp- n = 196; neu-/pfp+ n = 
150; neu-/pfp- n = 168; neu-/IL15- n = 126). *, p < 
0,05, **, p < 0,01, chi-square test with Yates’ 
correction. (B and C) Immunohistochemistry for γδ 
T cells in female (B) and male (C) mammary bud 
at E14.5. The bud is fully formed. The epithelial 
cells are arrayed in an inverted bulb shape. The 
mesenchymal cells are arranged in four to five 
layers in a radial fashion around the epithelial cells. 
A couple of γδ T cells (arrows) are visible only 
close the male bud. Magnification x400. (D) 
Frequency of mammary remnants displaying 
microscopic tumors in whole mount examined 
from 20-30 week-old neu+/pfp+ (n = 50) and 
neu+/pfp- (n = 36) male mice. **, p< 0,01, chi-
square test with Yates’ correction. 
 
